Effect of diabetes mellitus on hemodynamic and cardiometabolic correlates in experimental myocardial infarction

Advances in Experimental Medicine and Biology

Volumn 498, Issue , 2001, Pages 229-240

  Gupta, Suresh K ^a   Arya, Dharamveer S ^a   Singh, Uma ^a   Talwar, Kewal K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; EXPERIMENTATION; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE METABOLISM; HEART MUSCLE NECROSIS; HEMODYNAMIC MONITORING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALIA;

EID: 0035699031     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-1321-6_29     Document Type: Conference Paper

References (45)

1. Diabetic cardiomyopathy
2. Role of diabetes in congestive heart failure. The Framingham study
3. Preclinical abnormality of left ventricular function in diabetes mellitus
4. Left ventricular function in diabetes mellitus I: Methodology and prevalence and spectrum of abnormalities
5. Evidence of cardiomyopathy in familial diabetes mellitus
6. Role of diabetes in cardiac disease: Conclusions from population studies
7. Morbidity and mortality in diabetics in the Framingham population: Sixteen year follow-up study
8. Survival of diabetic patients after myocardial infarction
9. The contribution of diabetes to early deaths from ischemic heart disease. US gender and racial comparisons
10. Mortality in diabetes mellitus - Data from a developing region of the World
11. Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs
12. Effects of ischemia on rat myocardial function and metabolism in diabetes
13. Altered myocardial mechanics in diabetic rats
14. Diabetes- induced abnormalities in the myocardium
15. The effects of diabetes on performance and metabolism of rat hearts
16. Cardiac function in normal and diabetic rats
17. Alterations in cardiac performance in experimentally-induced diabetes
18. Basal developed force and inotropic characteristics of myocardial tissue isolated from streptozotocin diabetic animals
19. The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance
20. Effect of chronic streptozotocin-induced diabetes on cardiac performance in rats
21. A possible role of noradrenalin in the development of myocardial infarction: An experimental study in the isolated rat heart
22. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat
23. Decreased myocardial calcium uptake after isoproterenol in streptozotocin-induced diabetic rats
24. Studies of the diabetogenic action of streptozotocin
25. Drugs producing diabetes through damage of the insulin secreting cells
26. Determination of creatine phosphate and adenosine triphosphate with creatine kinase, phosphoglycerate kinase and glyceraldehyde phosphate dehydrogenase
27. Lactate determination
28. Determination of glycogen in small tissue samples
29. Lactic dehydrogenase activity in blood
30. Protein measurement with folin phenol reagent
31. Studies on the diabetogenic action of streptozotocin
32. A comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan
33. Myocardial and metabolic abnormalities in streptozotocin-diabetic Wistar and Wistar-Kyoto rats
34. Cardiotoxicity of high doses of isoproterenol on cardiac hemodynamics and metabolism in SHR and WHY rats
35. Effect of insulin replacement on streptozotocin-induced effects in the rat heart
36. Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes
37. Prevention of diabetes-induced myocardial dysfunction in rats by methyl palmoxirate and triiodothyronine treatment
38. Effects of hydralazine on streptozotocin-induced diabetic rats: Prevention of hyperlipidemia and improvement in cardiac function
39. 4
40. Diabetes and the survival and recovery of the anoxic myocardium
41. Altered cardiac automaticity and conduction in experimental diabetes mellitus
42. New type of cardiomyopathy associated with diabetic glomerulosclerosis
43. Diabetes alters the myocardial cAMP protein kinase cascade system
44. Cardiac alpha and beta adrenergic receptor alterations in diabetic cardiomyopathy
45. Pathogenesis of cardiac dysfunction in diabetes mellitus